Infectious virus shedding duration reflects secretory IgA antibody response latency after SARS-CoV-2 infection S Miyamoto, T Nishiyama, A Ueno, H Park, T Kanno, N Nakamura, ... Proceedings of the National Academy of Sciences 120 (52), e2314808120, 2023 | 10 | 2023 |
Linkage mechanisms governed by integrable deformations of discrete space curves S Kaji, K Kajiwara, H Park Nonlinear systems and their remarkable mathematical structures, 356-381, 2019 | 10 | 2019 |
Potential anti-monkeypox virus activity of atovaquone, mefloquine, and molnupiravir, and their potential use as treatments D Akazawa, H Ohashi, T Hishiki, T Morita, S Iwanami, KS Kim, YD Jeong, ... BioRxiv, 2022.08. 02.502485, 2022 | 9 | 2022 |
Isolation may select for earlier and higher peak viral load but shorter duration in SARS-CoV-2 evolution J Sunagawa, H Park, KS Kim, R Komorizono, S Choi, L Ramirez Torres, ... Nature Communications 14 (1), 7395, 2023 | 4 | 2023 |
Potential anti-mpox virus activity of atovaquone, mefloquine, and molnupiravir, and their potential use as treatments D Akazawa, H Ohashi, T Hishiki, T Morita, S Iwanami, KS Kim, YD Jeong, ... The Journal of infectious diseases 228 (5), 591-603, 2023 | 4 | 2023 |
Stratifying elicited antibody dynamics after two doses of SARS-CoV-2 vaccine in a community-based cohort in Fukushima, Japan N Nakamura, Y Kobashi, KS Kim, Y Tani, Y Shimazu, T Zhao, ... medrxiv, 2022.06. 11.22276266, 2022 | 4 | 2022 |
A personalized antibody score for predicting individual COVID-19 vaccine-elicited antibody levels from basic demographic and health information N Nakamura, H Park, KS Kim, Y Sato, YD Jeong, S Iwanami, Y Fujita, ... medrxiv, 2022.07. 05.22277283, 2022 | 3 | 2022 |
Defocusing mKdV flow on centroaffine plane curves H Park, K Kajiwara, T Kurose, N Matsuura JSIAM Letters 10, 25-28, 2018 | 3 | 2018 |
Analysis of the risk and pre-emptive control of viral outbreaks accounting for within-host dynamics: SARS-CoV-2 as a case study WS Hart, H Park, YD Jeong, KS Kim, R Yoshimura, RN Thompson, ... Proceedings of the National Academy of Sciences 120 (41), e2305451120, 2023 | 2 | 2023 |
Relationship between the inclusion/exclusion criteria and sample size in randomized controlled trials for SARS-CoV-2 entry inhibitors D Tatematsu, M Akao, H Park, S Iwami, K Ejima, S Iwanami Journal of Theoretical Biology 561, 111403, 2023 | 2 | 2023 |
Isoperimetric deformations of curves on the Minkowski plane H Park, J Inoguchi, K Kajiwara, K Maruno, N Matsuura, Y Ohta International Journal of Geometric Methods in Modern Physics 16 (07), 1950100, 2019 | 2 | 2019 |
Multiscale modeling of HBV infection integrating intra-and intercellular viral propagation to analyze extracellular viral markers K Kitagawa, KS Kim, M Iwamoto, S Hayashi, H Park, T Nishiyama, ... PLOS Computational Biology 20 (3), e1011238, 2024 | 1 | 2024 |
Modeling COVID-19 vaccine booster-elicited antibody response and impact of infection history T Nishiyama, Y Miyamatsu, H Park, N Nakamura, RY Shibata, S Iwami, ... Vaccine 41 (52), 7655-7662, 2023 | 1 | 2023 |
Multiscale modeling of HBV infection integrating intra-and intercellular viral propagation for analyzing extracellular viral markers K Kitagawa, KS Kim, M Iwamoto, S Hayashi, H Park, T Nishiyama, ... bioRxiv, 2023 | 1 | 2023 |
Contact-number-driven virus evolution: A multi-level modeling framework for the evolution of acute or persistent RNA virus infection J Sunagawa, R Komorizono, H Park, WS Hart, RN Thompson, A Makino, ... PLOS Computational Biology 19 (5), e1011173, 2023 | 1 | 2023 |
Modelling the effectiveness of isolation strategies for managing mpox outbreaks with variable infectiousness profiles YD Jeong, T Nishiyama, H Park, M Ishikane, N Iwamoto, K Aihara, ... MedRxiv, 2023.10. 04.23296551, 2023 | 1 | 2023 |
Modeling and predicting individual variation in COVID-19 vaccine-elicited antibody response in the general population N Nakamura, Y Kobashi, KS Kim, H Park, Y Tani, Y Shimazu, T Zhao, ... PLOS Digital Health 3 (5), e0000497, 2024 | | 2024 |
Stratification of viral shedding patterns in saliva of COVID-19 patients H Park, Y Raiki, S Iwanami, K Kim, K Ejima, N Nakamura, K Aihara, ... bioRxiv, 2024.01. 30.578034, 2024 | | 2024 |
Modeling lesion transition dynamics to clinically characterize mpox patients in the Democratic Republic of the Congo T Nishiyama, F Miura, YD Jeong, N Nakamura, H Park, M Ishikane, ... medRxiv, 2024.01. 28.24301907, 2024 | | 2024 |
Antibody Profiling of Microbial Antigens in the Blood of COVID-19 mRNA Vaccine Recipients Using Microbial Protein Microarrays H Saito, H Yoshimura, M Yoshida, Y Tani, M Kawashima, T Uchiyama, ... Vaccines 11 (11), 1694, 2023 | | 2023 |